| Troy Shields, MD | |
|
973 Mica Drive, Suite 201, Carson City, NV 89705 | |
| (775) 783-6190 | |
| Not Available |
| Full Name | Troy Shields |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 973 Mica Drive, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285011007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 20975 (Nevada) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renown South Meadows Medical Center | Reno, NV | Hospital |
| Carson Valley Medical Center | Gardnerville, NV | Hospital |
| Banner Lassen Medical Center | Susanville, CA | Hospital |
| Northern Nevada Medical Center | Sparks, NV | Hospital |
| Renown Regional Medical Center | Reno, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| James J Lynch M D Ltd | 9133188626 | 80 |
News Archive
Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta proteins, which are widely thought to cause Alzheimer's disease (AD).
Even prior to the onset of the economic recession in 2008, nearly one in four American parents with health insurance reported that their coverage was so inadequate they were unable to access the medical care their children needed.
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cancer Discovery.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
› Verified 9 days ago
| Entity Name | Tahoe Fracture And Orthopedic Medical Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750372140 PECOS PAC ID: 8628979267 Enrollment ID: O20040116000723 |
News Archive
Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta proteins, which are widely thought to cause Alzheimer's disease (AD).
Even prior to the onset of the economic recession in 2008, nearly one in four American parents with health insurance reported that their coverage was so inadequate they were unable to access the medical care their children needed.
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cancer Discovery.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
› Verified 9 days ago
| Entity Name | James J Lynch M D Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285649608 PECOS PAC ID: 9133188626 Enrollment ID: O20041008001262 |
News Archive
Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta proteins, which are widely thought to cause Alzheimer's disease (AD).
Even prior to the onset of the economic recession in 2008, nearly one in four American parents with health insurance reported that their coverage was so inadequate they were unable to access the medical care their children needed.
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cancer Discovery.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Troy Shields, MD 973 Mica Drive, Suite 201, Carson City, NV 89705 Ph: (775) 783-6190 | Troy Shields, MD 973 Mica Drive, Suite 201, Carson City, NV 89705 Ph: (775) 783-6190 |
News Archive
Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta proteins, which are widely thought to cause Alzheimer's disease (AD).
Even prior to the onset of the economic recession in 2008, nearly one in four American parents with health insurance reported that their coverage was so inadequate they were unable to access the medical care their children needed.
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cancer Discovery.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
› Verified 9 days ago
Dr. Joseph Patrick Walls, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 973 Mica Dr, Ste 201, Carson City, NV 89705 Phone: 775-783-6190 Fax: 775-783-6191 | |
Dr. Kent W Gabriel, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 W Nye Lane, Suite 102, Carson City, NV 89703 Phone: 775-885-8890 Fax: 775-885-8865 | |
Dr. Allen Myron Schnaser, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 907 Spencer St, Carson City, NV 89703 Phone: 775-882-3085 | |
Dr. Marco Mendoza, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 973 Mica Dr, Suite 201, Carson City, NV 89705 Phone: 775-783-6190 | |
Dr. Roger Paul Rogalski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 973 Mica Dr, Suite 201, Carson City, NV 89705 Phone: 775-783-6190 Fax: 775-783-6191 | |
Dr. Kyle Edward Swanson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 935 Mica Dr Ste 13, Carson City, NV 89705 Phone: 775-783-3065 Fax: 775-267-1829 |